Chemotherapy and Drug Information

Cancer scan could remove need for radiotherapy in cured patients

PET scan usage for patients with early stage Hodgkin lymphoma could potentially help them avoid unneeded radiotherapy.

First-in-class antibody shows clinical activity against advanced colorectal cancer

Sym004, a mixture of two anti-epidermal growth factor receptor (EGFR) antibodies, was found to be clinically active in patients with advanced colorectal cancer that had become anti-EGFR therapy resistant.

Personal protective equipment (PPE) guidelines for handling monoclonal antibodies (MABs)

Personal protective equipment (PPE) guidelines for handling monoclonal antibodies (MABs)

Is there a new consensus about wearing personal protective equipment (PPE) when handling monoclonal antibodies (MABs) for infusion?

Possible treatment identified for lethal pediatric brain cancer

Possible treatment identified for lethal pediatric brain cancer

Gene-regulating drugs may be effective at treating diffuse intrinsic pontine gliomas (DIPG), research indicates.

Ad-REIC Gene Therapy: Promising Results in a Patient with Metastatic CRPC Following Chemotherapy

Ad-REIC Gene Therapy: Promising Results in a Patient with Metastatic CRPC Following Chemotherapy

[Clinical Medicine Insights] In this case study, a 63-year-old man with metastatic castration-resistant prostate cancer (CRPC) was successfully treated for two years with in situ gene therapy using an adenovirus vector carrying the human REIC/Dkk‑3 gene.

Chemobrain is a real cognitive effect

Chemotherapy, which can cause an inability to concentrate, is measurable effect related to cancer treatment.

Evidence grows that melanoma drugs benefit some lung cancer patients

Evidence grows that melanoma drugs benefit some lung cancer patients

Drugs that are more commonly used to treat melanoma can also be use to help some individuals with lung cancer, research indicates.

Changes in cancer epigenome implicated in chemotherapy resistance and lymphoma relapse

New research indicate that malfunctioning genes are only partly to blame for why treatment that was effective ultimately fails in many patients with the most common form of non-Hodgkin lymphoma.

Immunotherapy drug pembrolizumab shows promise for patients with mesothelioma

The PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in approximately 76% of patients with pleural mesothelioma.

Breast cancer and chemobrain: Stress of diagnosis can impair cognitive function before chemotherapy is started

Milder cognitive defects displayed by breast cancer patient even before the initiation of chemotherapy may be attributable to disease-related posttraumatic stress, new study data indicates.

Stat Consult Slideshows

Fluorouracil (5-FU)

This slideshow reviews fluorouracil (5-FU), indicated for palliative treatment of breast cancer, colorectal cancer, gastric cancer, and carcinoma of the pancreas; also adjuvant treatment of colorectal cancer.

Netupitant/Palonosetron (Akynzeo)

This slideshow reviews netupitant/palonosetron (Akynzeo), indicated for prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy.

Bevacizumab (Avastin) - cervical cancer

This slideshow reviews bevacizumab (Avastin), indicated for cervical cancer, in combination with paclitaxel and cisplatin or paclitaxel and topotecan in persistent, recurrent, or metastatic disease.

To view all content in our Stat Consult section, please click here.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs